Rhenium Re 186 etidronate
N/A
Report date: 2024/06/18 20:00:07
NME
Base Information
Drug NameRhenium Re 186 etidronate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMallinckrodt
China Registration ClassN/A
Develop Information
Active CompaniesNational Heart, Lung, And Blood Institute (Nhlbi)
Inactive CompaniesMallinckrodt
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A